Inventor
PEARCE BRADLEY C
US19 patents
⚠️ This page may combine multiple inventors who share the name “PEARCE BRADLEY C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
18 patentsUS5217992AJun 8, 1993
Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
BRISTOL MYERS SQUIBB CO45 citations95
US5348974ASep 20, 1994
Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
BRISTOL MYERS SQUIBB CO37 citations92
US5318993AJun 7, 1994
Antihyperlipidemic benzoquinones
BRISTOL MYERS SQUIBB CO32 citations92
US6506738B1Jan 14, 2003
Benzimidazolone antiviral agents
BRISTOL MYERS SQUIBB CO47 citations91
US7396830B2Jul 8, 2008
Piperazine amidines as antiviral agents
BRISTOL MYERS SQUIBB CO16 citations84
US5434154AJul 18, 1995
Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkylpiperazines
BRISTOL MYERS SQUIBB CO19 citations82
US5393776AFeb 28, 1995
Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
BRISTOL MYERS SQUIBB CO19 citations81
US5391765AFeb 21, 1995
Cholesterol lowering/antioxidant nitroxides
BRISTOL MYERS SQUIBB CO7 citations74
US5296508AMar 22, 1994
Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
BRISTOL MYERS SQUIBB CO10 citations73
US5204373AApr 20, 1993
Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
BRISTOL MYERS SQUIBB CO11 citations73
US5411969AMay 2, 1995
Antihyperlipidemic/antioxidant dihydroquinolines
BRISTOL MYERS SQUIBB CO4 citations63
US6774134B2Aug 10, 2004
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
BRISTOL MYERS SQUIBB CO5 citations61
US11166959B2Nov 9, 2021
Isofuranone compounds useful as HPK1 inhibitors
BRISTOL MYERS SQUIBB CO1 citations59
US5627192AMay 6, 1997
Antihyperlipidemic/antioxidant dihydroquinolines
BRISTOL MYERS SQUIBB CO1 citations52
US8362004B2Jan 29, 2013
Piperazine analogs as broad-spectrum influenza antivirals
BRISTOL MYERS SQUIBB CO1 citations50
US6844342B2Jan 18, 2005
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
BRISTOL MYERS SQUIBB CO0 citations50
US9598423B2Mar 21, 2017
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
BRISTOL MYERS SQUIBB CO0 citations45
US9273058B2Mar 1, 2016
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
BRISTOL MYERS SQUIBB CO1 citations45